Literature DB >> 4343379

[Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].

R D Hesch, W Gerlach, H V Henning, D Emrich, F Scheler, R Kattermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4343379     DOI： 10.1055/s-0028-1107640

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  6 in total

1.  Dailysate calcium and plasma calcium fractions during and after haemodialysis.

Authors:  C Fuchs; M Brasche; U Donath-Wolfram; J Kubosch; E Quellhorst; F Scheler
Journal:  Klin Wochenschr       Date:  1975-01

2.  [The use of photon absorptiometry in renal osteodystrophy (author's transl)].

Authors:  A Samizadeh; H Loew; G Busch; H Müller; H Losse
Journal:  Klin Wochenschr       Date:  1977-10-15

3.  [Final remark on the preceeding discussion comment].

Authors:  H P Breuel; R D Hesch; H V Henning; H Luig; D Emrich
Journal:  Klin Wochenschr       Date:  1974-06-01

4.  Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

Authors:  D von Herrath; K Schaefer; D Kraft; H G Grigoleit; P Koeppe
Journal:  Klin Wochenschr       Date:  1973-10-01

Review 5.  Digitalis pharmacokinetics and therapy with respect to impaired renal function.

Authors:  P Kramer
Journal:  Klin Wochenschr       Date:  1977-01-01

6.  The effect of 5,6-trans-25-hydroxycholecalciferol in relative vitamin D resistancy.

Authors:  D Kraft; G Offermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.